Header Forschung

Otorhinolaryngology – Head and Neck Surgery

The Department of Otorhinolaryngology, Head and Neck surgery at Dresden Medical School treats more than 400 cases of malignancies per year. The primary sides include malignancies of the oral cavity, the pharynx, the larynx, the salivary glands, the nasal cavity, the paranasal sinuses, the skull base, the neck and the skin. Additionally, we annually take care of more than 150 patients with benign lesions in the above mentioned localizations. In order to cure and to minimize surgery related side effects we carefully select the optimal approach including transoral laser assisted surgery, endoscopic and or microscopic surgery and reconstructive techniques together with microvascular flaps.

Our scientific focus is on biomarkers that enable an individualized treatment for squamous cell carcinoma of the head and neck. Additionally, we carry out clinical trials to establish the best treatment for our patients. 

Another focus are biomarkers in patients with paraganglioma in the head and neck that give information about the dignity and the clinical course of the disease.

Own recent publications

FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
Zschaeck S, Löck S, Leger S, Haase R, Bandurska-Luque A, Appold S, Kotzerke J, Zips D, Richter C, Gudziol V, Schreiber A, Zöphel K, Baumann M, Krause M. Radiother Oncol. 2017 Mar;122(3):437-444.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG.
Linge A, Löck S, Gudziol V, Nowak A, Lohaus F, von Neubeck C, Jütz M, Abdollahi A, Debus J, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Bayer C, Belka C, Pigorsch S, Combs SE, Welz S, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Baumann M, Krause M; DKTK-ROG. Clin Cancer Res. 2016 Jun 1;22(11):2639-49

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A, Lohaus F, Löck S, Nowak A, Gudziol V, Valentini C, von Neubeck C, Jütz M, Tinhofer I, Budach V, Sak A, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Buchholz F, Aust DE, Baretton GB, Thames HD, Dubrovska A, Alsner J, Overgaard J, Krause M, Baumann M; DKTK-ROG. Radiother Oncol. 2016 Dec;121(3):364-373

Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure.
Zschaeck S, Haase R, Abolmaali N, Perrin R, Stützer K, Appold S, Steinbach J, Kotzerke J, Zips D, Richter C, Gudziol V, Krause M, Zöphel K, Baumann M. Acta Oncol. 2015;54(9):1355-63

FDG PET/MR for lymph node staging in head and neck cancer.
Platzek I, Beuthien-Baumann B, Schneider M, Gudziol V, Kitzler HH, Maus J, Schramm G, Popp M, Laniado M, Kotzerke J, van den Hoff J. Eur J Radiol. 2014 Jul;83(7):1163-8